🎉 M&A multiples are live!
Check it out!

Nanosonics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nanosonics and similar public comparables like Myomo, InfuSystem, and SmartVest.

Nanosonics Overview

About Nanosonics

Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.


Founded

2000

HQ

Australia
Employees

466

Financials

LTM Revenue $118M

LTM EBITDA $14.2M

EV

$740M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Nanosonics Financials

Nanosonics has a last 12-month revenue of $118M and a last 12-month EBITDA of $14.2M.

In the most recent fiscal year, Nanosonics achieved revenue of $108M and an EBITDA of $13.7M.

Nanosonics expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Nanosonics valuation multiples based on analyst estimates

Nanosonics P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $106M $108M XXX XXX XXX
Gross Profit $57.7M $83.6M XXX XXX XXX
Gross Margin 55% 77% XXX XXX XXX
EBITDA $18.7M $13.7M XXX XXX XXX
EBITDA Margin 18% 13% XXX XXX XXX
Net Profit $2.4M $12.6M XXX XXX XXX
Net Margin 2% 12% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Nanosonics Stock Performance

As of March 17, 2025, Nanosonics's stock price is AUD 4 (or $3).

Nanosonics has current market cap of AUD 1.3B (or $826M), and EV of AUD 1.2B (or $740M).

See Nanosonics trading valuation data

Nanosonics Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$740M $826M XXX XXX XXX XXX $0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Nanosonics Valuation Multiples

As of March 17, 2025, Nanosonics has market cap of $826M and EV of $740M.

Nanosonics's trades at 6.3x LTM EV/Revenue multiple, and 52.1x LTM EBITDA.

Analysts estimate Nanosonics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Nanosonics and 10K+ public comps

Nanosonics Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $740M XXX XXX XXX
EV/Revenue 6.4x XXX XXX XXX
EV/EBITDA 50.2x XXX XXX XXX
P/E 89.2x XXX XXX XXX
P/E/Growth 2.6x XXX XXX XXX
EV/FCF 61.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Nanosonics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Nanosonics Valuation Multiples

Nanosonics's NTM/LTM revenue growth is 12%

Nanosonics's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Nanosonics's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Nanosonics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Nanosonics and other 10K+ public comps

Nanosonics Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 2% XXX XXX XXX XXX
EBITDA Margin 13% XXX XXX XXX XXX
EBITDA Growth -26% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 25% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 38% XXX XXX XXX XXX
G&A Expenses to Revenue 16% XXX XXX XXX XXX
R&D Expenses to Revenue 19% XXX XXX XXX XXX
Opex to Revenue 78% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Nanosonics Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Nanosonics M&A and Investment Activity

Nanosonics acquired  XXX companies to date.

Last acquisition by Nanosonics was  XXXXXXXX, XXXXX XXXXX XXXXXX . Nanosonics acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Nanosonics

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Nanosonics

When was Nanosonics founded? Nanosonics was founded in 2000.
Where is Nanosonics headquartered? Nanosonics is headquartered in Australia.
How many employees does Nanosonics have? As of today, Nanosonics has 466 employees.
Who is the CEO of Nanosonics? Nanosonics's CEO is Mr. Michael Kavanagh.
Is Nanosonics publicy listed? Yes, Nanosonics is a public company listed on ASX.
What is the stock symbol of Nanosonics? Nanosonics trades under NAN ticker.
When did Nanosonics go public? Nanosonics went public in 2007.
Who are competitors of Nanosonics? Similar companies to Nanosonics include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Nanosonics? Nanosonics's current market cap is $826M
What is the current revenue of Nanosonics? Nanosonics's last 12-month revenue is $118M.
What is the current EBITDA of Nanosonics? Nanosonics's last 12-month EBITDA is $14.2M.
What is the current EV/Revenue multiple of Nanosonics? Current revenue multiple of Nanosonics is 6.3x.
What is the current EV/EBITDA multiple of Nanosonics? Current EBITDA multiple of Nanosonics is 52.1x.
What is the current revenue growth of Nanosonics? Nanosonics revenue growth between 2023 and 2024 was 2%.
Is Nanosonics profitable? Yes, Nanosonics is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.